✦ LIBER ✦

Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines

✍ Scribed by Manabu Hirata; Masaki Itoh; Akira Tsuchida; Hideo Ooishi; Keiji Hanada; Goro Kajiyama

Book ID: 115932211
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 366 KB
Volume: 383
Category: Article
ISSN: 0014-5793
DOI: 10.1016/0014-5793(96)00245-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Loxiglumide (CR1505), a cholecystokinin

Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice

✍ Yoshinori Nio; Michihiko Tsubono; Hideki Morimoto; Kazuya Kawabata; Yoshikazu Ma 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 718 KB

Cholecystokinin receptors in human pancr

Cholecystokinin receptors in human pancreatic cancer cell lines

✍ K.K. Mandair; P. Towner; I.F. Stamford; J.D. Morris; E. Harper; I.S. Benjamin; I 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Cholecystokinin regulates the invasivene

Cholecystokinin regulates the invasiveness of human pancreatic cancer cell lines via protein kinase C pathway

✍ Hirata, Manabu; Tsuchida, Akira; Iwao, Toshiyasu; Eguchi, Noriaki; Sasaki, Tamit 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Growth inhibition of human pancreatic ca

Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice

✍ Funakoshi, Akihiro ;Kono, Akira 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 700 KB

Transfected cholecystokinin receptors me

Transfected cholecystokinin receptors mediate growth inhibitory effects on human pancreatic cancer cell lines

✍ K Detjen; MC Fenrich; CD Logsdon 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Inhibitory effects of a cholecystokinin

Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer

✍ Hideki Morimoto; Dr. Yoshinori Nio; Michihiko Tsubono; Chen-Chiu Tseng; Kazuya K 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

The effects of cholecystokinin (CCK) and a CCK antagonist, loxiglumide (CR-1505), on four freshly separated and six xenografted human pancreatic cancers, were investigated. The level of DNA synthesis in only one of five tested pancreatic cancers was enhanced by CCK at concentrations of 0.01-10 nM, w